AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

NCT ID: NCT06346392

This clinical trial is studying a new treatment called AZD0901 for patients with advanced or metastatic gastric cancer or gastroesophageal junction cancer that expresses a specific protein known as...

Recruiting

Phase: PHASE3 Type: interventional Locations: Washington, District Of Columbia, United States, Charlottesville, Virginia, United States +183 more

Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer Surgery

NCT ID: NCT07119463

This clinical trial is studying whether giving patients a medicine called albumin, based on specific blood levels, can help reduce serious complications after stomach cancer surgery. Albumin is a p...

Recruiting

Phase: PHASE2 Type: interventional Locations: Changchun, Jilin, China

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

NCT ID: NCT06503146

This clinical trial is studying a new imaging method using a special substance called 18F-FAPI-74 to help detect certain types of cancer more effectively. The goal is to find out if this new tracer...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bethesda, Maryland, United States

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

NCT ID: NCT06695845

This clinical trial is studying a new treatment called zanidatamab for patients with certain types of solid tumors that have high levels of a protein called HER2. These tumors include breast, gastr...

Recruiting

Phase: PHASE2 Type: interventional Locations: Detroit, Michigan, United States, Houston, Texas, United States +20 more

Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis

NCT ID: NCT04557969

This clinical trial is focused on studying gastrointestinal stromal tumors (GISTs), a type of cancer that can occur in the stomach and intestines. The main goal is to gather tissue samples from the...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

NCT ID: NCT06731478

This clinical trial is exploring a new treatment approach for adults with advanced HER2-positive gastric or gastroesophageal junction (GEJ) cancer. Researchers want to see if a combination of three...

Recruiting

Phase: PHASE3 Type: interventional Locations: Bronx, New York, United States, Toronto, , Canada +244 more

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

NCT ID: NCT06999187

This clinical trial is looking at a new treatment called DR-0202 for patients with certain types of advanced cancers, including triple-negative breast cancer and non-small cell lung cancer, among o...

Recruiting

Phase: PHASE1 Type: interventional Locations: Fairfax, Virginia, United States, Denver, Colorado, United States +8 more

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

NCT ID: NCT06298916

This clinical trial is exploring a new imaging agent called 64Cu-LNTH-1363S, which is designed to help doctors see certain types of cancer better during scans. Specifically, the study is looking at...

Recruiting

Phase: PHASE1 Type: interventional Locations: Cincinnati, Ohio, United States, Duarte, California, United States +3 more

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

NCT ID: NCT05208762

This clinical trial is studying a new drug called PF-08046054/SGN-PDL1V to see how safe it is for patients with advanced solid tumors, which are cancers that have spread in the body or cannot be su...

Recruiting

Phase: PHASE1 Type: interventional Locations: Iowa City, Iowa, United States, Milano, , Italy +73 more

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

NCT ID: NCT06257264

This clinical trial is studying a new treatment called BG-68501 for patients with advanced-stage tumors, including certain types of breast cancer, lung cancer, ovarian cancer, and others. The main ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Saint Louis, Missouri, United States, Brisbane, Queensland, Australia +44 more

STK-012 Monotherapy and in Combination Therapy in Patients With Solid Tumors

NCT ID: NCT05098132

This clinical trial is looking at a new treatment called STK-012 for patients with certain advanced solid tumors, which are types of cancer that form in various organs. The trial will test STK-012 ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States +27 more

Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation

NCT ID: NCT05899985

This clinical trial is exploring a new method called the FerroTrace® system for identifying sentinel lymph nodes (SLNs) in patients with gastric and esophageal cancers. These nodes are the first pl...

Recruiting

Phase: NA Type: interventional Locations: Adelaide, South Australia, Australia, Heidelberg, Victoria, Australia +2 more

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

NCT ID: NCT06219941

This clinical trial is studying a new treatment called AZD0901 for patients with advanced solid tumors that express a protein known as Claudin18.2. The trial aims to find out how safe and effective...

Recruiting

Phase: PHASE2 Type: interventional Locations: Barcelona, , Spain, Houston, Texas, United States +44 more

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

NCT ID: NCT06395519

This clinical trial is studying a new medication called ETX-19477, which targets a specific enzyme involved in cancer growth. Researchers want to find out how safe the drug is, how the body process...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, Boston, Massachusetts, United States +11 more

A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer

NCT ID: NCT07110571

This clinical trial is studying new treatment combinations for people with stomach cancer or cancer where the stomach meets the esophagus (the tube that carries food from the mouth to the stomach)....

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Hangzhou, Zhejiang, China, Shijiazhuang, Hebei, China

Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric Cancer

NCT ID: NCT07085273

This clinical trial is studying a new treatment approach for people with gastric cancer, which is cancer that starts in the stomach. The trial is testing a combination of medicines, including a spe...

Not yet recruiting

Phase: PHASE2 Type: interventional

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

NCT ID: NCT03228667

The QUILT-3.055 clinical trial is studying new combination treatments for patients with advanced solid tumors, such as lung, kidney, and skin cancers, who have not responded to previous immune ther...

Recruiting

Phase: PHASE2 Type: interventional Locations: Charleston, South Carolina, United States, Buffalo, New York, United States +33 more

A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

NCT ID: NCT06038578

This clinical trial is studying a new treatment called TRK-950, which will be given together with two existing medications, ramucirumab and paclitaxel, to see if this combination is effective for t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Duarte, California, United States, Kashiwa, Chiba, Japan +30 more

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

NCT ID: NCT05891171

This clinical trial is studying a new treatment called AB598 for patients with advanced cancers, including types like bladder, cervical, lung, and breast cancer, among others. The main goal is to s...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, New Orleans, Louisiana, United States +25 more

Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

NCT ID: NCT04069273

This clinical trial is studying a new treatment approach for patients with advanced gastric or gastroesophageal adenocarcinoma, which is a type of stomach cancer. The trial aims to evaluate the eff...

Recruiting

Phase: PHASE2 Type: interventional Locations: Milwaukee, Wisconsin, United States, Rochester, Minnesota, United States

Main Menu

Clinical Trials for Gastric Cancer

452 Active Trials Found

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer Surgery

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

STK-012 Monotherapy and in Combination Therapy in Patients With Solid Tumors

Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer

Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric Cancer

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

Related Conditions